Table 2.

Summary of pathologic characteristics of the study population.

	ADT (n=101)	No ADT (n=196)	p-value
Path T Stage, n (%)
<pT2c	19 (18.8%)	23 (11.7%)	0.4
pT2c	51 (50.5%)	112 (57.1%)
pT3a	15 (14.9%)	26 (13.3%)
pT3b	16 (15.8%)	35 (17.9%)
Total Lymph Nodes Removed, median (IQR)	3 (0 – 6)	4 (3 – 6)	0.001
Total LN Positive, median (IQR)	2 (1 – 2)	1.5 (1 – 2)	1.0
Path Node Status, n (%)	3 (3.0%)	6 (3.1%)	1.0
Surgical Gleason Score, n (%)
≤6	23 (22.8%)	40 (20.4%)	<0.0001
7	42 (41.6%)	123 (62.8%)
≥8	19 (18.8%)	33 (16.8%)
Surgical Margins, n (%)	25 (24.8%)	61 (31.1%)	0.2
SV Invasion, n (%)	16 (15.8%)	35 (17.9%)	0.3
ExtraCapsular Extension, n (%)	23 (22.8%)	53 (27.0%)	0.3